As we grow our sometimes comedic “Mo’s” and smile in solidarity at our fellow participants, it is important to remember that at the heart of this initiative is a very important cause and some rather thought-provoking statistics.
As a global leader in providing unbiased, accurate and up-to-the-minute news and information to our customers across a variety of professions, it is essential that trust remain a cornerstone of how we do business. For more clarity on trust and its role within each of our businesses, we talked with several of our business leaders to gather their thoughts on the importance of trust in the professional areas we serve.
01 Nov 2013Chris Kibarian
“Trust is the cornerstone of our business. For more than half a century, professionals in academic institutions, corporations, government agencies, law firms and other businesses have trusted our high-quality curated data and leading-edge tools to drive the discovery, development and delivery of the world’s greatest innovations.
More than 20 million users at 15,000 organizations rely on our solutions to make business-critical decisions every day. They trust our skilled field experts to provide accurate, insightful counsel. And they count on us to protect their most valuable intellectual assets and global brands, acting with the highest standards of integrity.”
Read the full article to hear more from our business leaders on what trust means to them.
“Carbon emissions know no boundaries. The effects of global warming are extremely urgent. This is a human race epidemic.”
Chris Kibarian, president of Thomson Reuters IP & Science, led a panel of thought leaders at the Aspen Ideas Festival titled “Powering Tomorrow,” on the challenges effecting our transition to clean, renewable energy as a primary source powering our world. The panelists alongside Chris were Dr. Kristina Johnson, CEO of EnduringHydro; Michael Levi, author of “The Power Surge;” Mick Sawka, director of business development at Harvard University; and, Jeff Logan, senior energy analyst for the National Renewable Energy Lab. They focused on solar, wind, hydro and biofuels as the main renewable sources in their conversation.
The panel explored government policies, financing, competition, globalization and other important aspects related to this critical subject. One sentiment that was repeated by all panelists was that government policy pushing renewable use is a vital component of its adoption. However, and unfortunately, as Levi said, “The ‘pulse’ in Washington is the patient is dead.”
Today was filled with sessions that explored important and complex topics such as science, the arts, the Republican party, the Middle East, religious pluralism and energy.
27 Jun 2013Thomson Reuters
In tonight’s session, “Where does Obama Go From Here?” Chrystia Freeland, Reuters digital editor, will join the conversation with other top journalists to discuss the president’s ambitious and complex agenda.
Tomorrow morning, Reuters president and editor-in-chief Stephen J. Adler will join a Knowledge Exchange session underwritten by Thomson Reuters called “You, the Worldwide Leader in News.” Adler will be joined by Alexis Ohanian, Ezra Klein, Steve Clemons and Reena Ninan to discuss new research by Thomson Reuters that has uncovered important insights on how today’s professional is operating in a transformative age.
Monique Villa, CEO of the Thomson Reuters Foundation, will provide her insight and expertise later in the morning as she moderates a paneled discussion, “Women and the Arab Revolutions: Have They Been Helped or Hurt?”
Chris Kibarian, president of our Intellectual Property & Science business, will join the renewable energy conversation by moderating a Knowledge Exchange session titled “Powering Tomorrow” that will showcase a perspective on global warming’s impact on the environment and projected future ramifications.
Our leaders will once again participate in the influential conversations taking place at this year’s Aspen Ideas Festival, which will be held June 26 – July 3. We’re honored to be partnering with the Aspen Institute and The Atlantic for the sixth year to underwrite this unique gathering.
The Aspen Ideas Festival, now in its ninth year, assembles some of the world’s most influential thinkers and leaders to discuss their work and the issues that inspire them. This year’s Festival will explore a wide range of topics and issues, including:
The festival’s second Thomson Reuters Knowledge Exchange event was titled “Cracking the Genetic Code,” and featured an excellent panel. Moderated by Chris Kibarian, president of our IP & Science business, the panel included Harvard professor John Quackenbush, Brian Fiske of the The Michael J. Fox Foundation, and Paul Rejto from Pfizer. The three panelists each brought a unique perspective to the discussion, and their varied expertise helped to turn complicated subject matter into something very easy to understand and enjoy.
The conversation started and revolved around the human genome, and the project to determine the sequence of chemical base pairs which make up DNA, as well as identifying the function of human genes. Professor Quackenbush almost poetically explained complicated scientific information so that it was easily comprehensible. He talked about the roadmap of the human genome and the new technologies that have contributed to the decreasing costs of identifying genes. He talked about a time in the very near future where the cost would become so low that we’d be able to generate huge amounts of data in an economically responsible manner. This data would then contribute to a better understanding about genetic factors contributing to risk of developing diseases and being able to develop more personalized care for serious illnesses. (more…)
In part two of the Thomson Reuters Knowledge Exchange session titled “Cracking The Genetic Code,” Chris Kibarian moderates a panel with Brian Fiske, John Quackenbush and Paul Rejto about the types of scientific advancements needed to develop the treatments and life saving therapeutics that will change and improve human kind.
In part one of the Thomson Reuters Knowledge Exchange session titled “Cracking The Genetic Code,” Chris Kibarian moderates a panel with Brian Fiske, John Quackenbush and Paul Rejto about the types of scientific advancements needed to develop the treatments and life saving therapeutics that will change and improve human kind.